Declaratory Orders For Drug Firms Could Come Easier With High Court Ruling
This article was originally published in The Tan Sheet
Executive Summary
The first application of a recent Supreme Court decision which appears to ease the way for declaratory judgment actions by ANDA filers could come in a case brought by Teva against Novartis regarding Famvir